MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii

Journal of Medical Microbiology

Volumn 58, Issue 12, 2009, Pages 1607-1610

  Silveira, Carolina Pereira ^a   Torres Rodríguez, Josep M ^b,c   Alvarado Ramírez, Eidi ^b,c   Murciano Gonzalo, Francisca ^b   Dolande, Maribel ^d   Panizo, Mercedes ^d   Reviakina, Vera ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Mycology Department   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; TERBINAFINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BRAZIL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG USE; FUNGICIDAL ACTIVITY; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; NONHUMAN; PERU; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; SPAIN; SPOROTHRIX SCHENCKII; URUGUAY; VENEZUELA;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; MICROBIAL SENSITIVITY TESTS; SOUTH AMERICA; SPOROTHRIX;

EID: 73449139780     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.007609-0     Document Type: Article

References (19)

1. Alvarado-Ramírez, E. & Torres-Rodríguez, J. M. (2007). In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. Antimicrob Agents Chemother 51, 2420-2423.
2. Baker, J. H., Goodpasture, H. C., Kuhns, H. R., Jr & Rinaldi, M. G. (1989). Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole. Arch Pathol Lab Med 113, 1279-1281.
3. Bonifaz, A., Saúl, A., Paredes-Solis, V., Fierro, L., Rosales, A., Palacios, C. & Araiza, J. (2007). Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol 24, 369-372.
4. -1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 47, 62-68.
5. Ellis, D. (2002). Amphotericin B: spectrum and resistance. J Antimicrob Chemother 49, 7-10.
6. Espinel-Ingroff, A., Fothergill, A., Meter, J., Rinaldi, M. G. & Walsh, T. J. (2002). Testing conditions for determination of minimum fungicidal concentrations to new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J Clin Microbiol 40, 3204-3208.
7. Kauffman, C. A. (1995). Old and new therapies for sporotrichosis. Clin Infect Dis 21, 981-985.
8. Kohler, L. M., Hamdan, J. S. & Ferrari, T. C. (2007). Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing. Diagn Microbiol Infect Dis 58, 117-120.
9. Kosinski, R. M., Axelrod, P., Rex, J. H., Burday, M., Sivaprasad, R. & Wreiole, A. (1992). Sporothrix schenckii fungemia without disseminated sporotrichosis. J Clin Microbiol 30, 501-503.
10. Marimon, R., Cano, J., Gené, J., Sutton, D. A., Kawasaki, M. & Guarro, J. (2007). Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 45, 3198-3206.
11. Marimon, R., Serena, C., Gené, J., Cano, J. & Guarro, J. (2008). In vitro susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother 52, 732-734.
12. McGinnis, M. R., Nordoff, N., Li, R. K., Pasarell, L. & Warnock, D. W. (2001). Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol 39, 369-371.
13. Mesa-Arango, A. C., Reyes-Montes, M. R., Pérez-Mejía, A., Navarro-Barranco, H., Souza, V., Zúñiga, G. & Toriello, C. (2002). Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of sporotrichosis. J Clin Microbiol 40, 3004-3011.
14. NCCLS (2002). Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, approved guideline M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards.
15. Neyra, E., Fonteyne, P. A., Swinne, D., Fauche, F., Bustamante, B. & Nolard, N. (2005). Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol 43, 1348-1352.
16. Pappas, P. G., Tellez, I., Deep, A. E., Nolasco, D., Holgado, W. & Bustamante, B. (2000). Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 30, 65-70.
17. Ramos-e-Silva, M., Vasconcelos, C., Carneiro, S. & Cestari, T. (2007). Sporotrichosis. Clin Dermatol 25, 181-187.
18. Scheinfeld, N. (2007). A review of the new antifungals: posaconazole, micafungin, and anidulafungin. J Drugs Dermatol 6, 1249-1251.
19. Vilela, R., Souza, G. F., Fernandez Cota, G. & Mendoza, L. (2007). Cutaneous and meningeal sporotrichosis in a HIV patient. Rev Iberoam Micol 24, 161-163.